StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$2.66−0.33 (-11.04%)

Close on Nov 17, 2026Market cap $98.90MP/E –Yield –

Armata Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Armata Pharmaceuticals's pe ratio was 1.5× on Jul 29, 2016, against 3.8× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2016Jul 29, 20161.5×−43.1
2015Dec 31, 201544.6×+41.3
2014Dec 31, 20143.2×–

More Armata Pharmaceuticals figures

See a number that looks wrong?